Aevi Genomic Medicine, LLC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$34.7M

380 transactions

Summary

Aevi Genomic Medicine, LLC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $20.6MSales: $3.6M33 insiders

Date	Insider	Type	Value
2020-06-09	COLA MICHAEL F(Chief Executive Officer)	Buy	$250K
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	$0
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	$0
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	$0
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	$0
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	$0
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	$0
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	$0
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	$0
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	$0
2020-02-03	NEIL GARRY ARTHUR(Chief Scientific Officer)	D	—
2020-02-03	COLA MICHAEL F(President and CEO)	D	$0
2020-02-03	COLA MICHAEL F(President and CEO)	D	$0
2020-02-03	COLA MICHAEL F(President and CEO)	D	$0
2020-02-03	COLA MICHAEL F(President and CEO)	D	$0
2020-02-03	COLA MICHAEL F(President and CEO)	D	$0
2020-02-03	COLA MICHAEL F(President and CEO)	D	$0
2020-02-03	COLA MICHAEL F(President and CEO)	D	$0
2020-02-03	COLA MICHAEL F(President and CEO)	D	$0
2020-02-03	COLA MICHAEL F(President and CEO)	D	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Aevi Genomic Medicine, LLC — Contributions, Lobbying & Contracts | Poliscope